Grace Therapeutics, Inc. Increase (Decrease) in Receivables
Grace Therapeutics, Inc. (GRCE) reported Increase (Decrease) in Receivables of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-13
- Grace Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2026-06-30 was $0.00.
- Grace Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2026-03-31 was $0.00.
- Grace Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2025-12-31 was $0.00.
- Grace Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. increase (decrease) in receivables for fiscal 2026 was -$106.00K.
- Grace Therapeutics, Inc. increase (decrease) in receivables for fiscal 2025 was -$596.00K.
- Grace Therapeutics, Inc. increase (decrease) in receivables for fiscal 2024 was -$80.00K, a 126.49% decline from fiscal 2023.
- Grace Therapeutics, Inc. increase (decrease) in receivables for fiscal 2023 was $302.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 3 month as first filed | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | -$106.00K 10-K · filed 2026-06-18 | ||||
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | -$106.00K 10-Q · filed 2026-02-12 | -$281.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$106.00K 10-Q · filed 2025-11-13 | -$281.00K derived: sum of 3 quarters · filed 2026-08-13 | -$395.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$106.00K 10-Q · filed 2026-08-13 | -$281.00K derived: sum of 2 quarters · filed 2026-08-13 | -$395.00K derived: sum of 3 quarters · filed 2026-08-13 | -$376.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | -$289.00K derived: sum of 2 quarters · filed 2026-06-18 | -$270.00K derived: sum of 3 quarters · filed 2026-06-18 | -$596.00K 10-K · filed 2026-06-18 | ||||
| 2024-12-31 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$95.00K derived: sum of 2 quarters · filed 2026-02-12 | -$421.00K 10-Q · filed 2026-02-12 | -$658.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-09-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$307.00K 10-Q · filed 2025-11-13 | -$544.00K derived: sum of 3 quarters · filed 2025-11-13 | -$422.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$326.00K 10-Q · filed 2025-08-12 | -$563.00K derived: sum of 2 quarters · filed 2025-08-12 | -$441.00K derived: sum of 3 quarters · filed 2025-08-12 | -$441.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | -$115.00K derived: sum of 2 quarters · filed 2025-06-23 | -$115.00K derived: sum of 3 quarters · filed 2025-06-23 | -$80.00K 10-K · filed 2025-06-23 | ||||
| 2023-12-31 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $122.00K derived: sum of 2 quarters · filed 2025-02-13 | $157.00K 10-Q · filed 2025-02-13 | $191.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-13 | $35.00K 10-Q · filed 2024-11-13 | $69.00K derived: sum of 3 quarters · filed 2024-11-13 | $696.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $35.00K 10-Q · filed 2024-08-09 | $69.00K derived: sum of 2 quarters · filed 2024-08-09 | $696.00K derived: sum of 3 quarters · filed 2024-08-09 | $771.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $661.00K derived: sum of 2 quarters · filed 2024-06-21 | $736.00K derived: sum of 3 quarters · filed 2024-06-21 | $302.00K 10-K · filed 2024-06-21 | -$302.00K 10-K · filed 2023-06-23 | |||
| 2022-12-31 | $627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $702.00K derived: sum of 2 quarters · filed 2024-02-12 | $268.00K 10-Q · filed 2024-02-12 | -$268.00K 10-Q · filed 2023-02-14 | -$42.00K derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-09-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$359.00K 10-Q · filed 2023-11-13 | -$669.00K derived: sum of 3 quarters · filed 2023-11-13 | -$1.25M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$434.00K 10-Q · filed 2023-08-11 | -$744.00K derived: sum of 2 quarters · filed 2023-08-11 | -$1.32M derived: sum of 3 quarters · filed 2023-08-11 | -$943.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$889.00K derived: sum of 2 quarters · filed 2023-06-23 | -$509.00K derived: sum of 3 quarters · filed 2023-06-23 | -$18.00K 10-K · filed 2023-06-23 | ||||
| 2021-12-31 | -$579.00K 10-Q · filed 2022-02-14 | -$199.00K derived: sum of 2 quarters · filed 2022-02-14 | $292.00K 10-Q · filed 2023-02-14 | -$292.00K 10-Q · filed 2022-02-14 | -$68.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-09-30 | $380.00K 10-Q · filed 2021-11-10 | -$287.00K 10-Q · filed 2022-11-14 | $287.00K 10-Q · filed 2021-11-10 | $511.00K derived: sum of 3 quarters · filed 2022-08-11 | $484.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-06-30 | $93.00K 10-Q · filed 2022-08-11 | -$93.00K 10-Q · filed 2021-08-12 | $131.00K derived: sum of 2 quarters · filed 2022-08-11 | $104.00K derived: sum of 3 quarters · filed 2022-08-11 | $223.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $11.00K derived: sum of 2 quarters · filed 2022-06-21 | $130.00K derived: sum of 3 quarters · filed 2022-06-21 | $58.00K 10-K · filed 2022-06-21 | -$58.00K 10-K · filed 2021-06-22 | |||
| 2020-12-31 | -$27.00K 10-Q · filed 2022-02-14 | $92.00K derived: sum of 2 quarters · filed 2022-02-14 | $20.00K 10-Q · filed 2022-02-14 | -$570.00K derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | $119.00K 10-Q · filed 2021-11-10 | $47.00K 10-Q · filed 2021-11-10 | -$543.00K derived: sum of 3 quarters · filed 2021-11-10 | -$306.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$71.00K 10-Q · filed 2021-08-12 | -$662.00K derived: sum of 2 quarters · filed 2021-08-12 | -$425.00K derived: sum of 3 quarters · filed 2021-08-12 | -$852.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-22 | -$354.00K derived: sum of 2 quarters · filed 2021-06-22 | -$781.00K derived: sum of 3 quarters · filed 2021-06-22 | -$581.00K 10-K · filed 2021-06-22 | ||||
| 2019-12-31 | $237.00K 10-Q · filed 2021-02-09 | -$190.00K derived: sum of 2 quarters · filed 2021-02-09 | $10.00K 10-Q · filed 2021-02-09 | |||||
| 2019-09-30 | -$427.00K 10-Q · filed 2020-11-16 | -$227.00K 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | $620.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |